Yan-Hua Zhang

Yan-Hua Zhang

Auto-generated profile, based on publicly available information

Yan-Hua Zhang

Hubei Provincial Key Laboratory of Green Materials for Light Industry

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2021 in Oncology Reports
Verified
Journal Article
Open access
PDF file
YLYang Liu
Yang Liu
NLNa Li
Na Li
MWMeng Wang
Meng Wang
YZYan-Hua Zhang
Yan-Hua Zhang
LYLu-Da Yan
Lu-Da Yan
SLShunshe Luo
Shunshe Luo
Non‑small cell lung cancer (NSCLC), which accounts for ~85% of all lung cancer cases, is commonly diagnosed at an advanced stage and has a high patient mortality rate. Despite the increasing availability of treatment strategies, the prognosis of patients with NSCLC remains poor, with a low 5‑year survival rate. This poor prognosis may be associated with the tumor heterogeneity of NSCLC, as well as its acquisition and intrinsic resistance to therapeutic drugs. It has been suggested that combination therapy with telomerase inhibition may be an effective strategy for the treatment of drug‑sensitive and drug‑resistant types of cancer. Telomerase is the key enzyme for cell survival, and ~90% of human cancers maintain telomeres by activating telomerase, which is driven by the upregulation of telomerase reverse transcriptase (TERT). Several mechanisms of telomerase reactivation have been described in a variety of cancer types, including TERT promoter mutation, epigenetic modifications via a TERT promoter, TERT amplification, and TERT rearrangement. The aim of the present study was to comprehensively review telomerase activity and its association with the clinical characteristics and prognosis of NSCLC, as well as analyze the potential mechanism via which TERT activates telomerase and determine its potential clinical application in NSCLC. More importantly, current treatment strategies targeting TERT in NSCLC have been summarized with the aim to promote discovery of novel strategies for the future treatment of NSCLC.

28 August 2025 in ACS Sustainable Chemistry & Engineering
Verified
Journal Article
Closed access
XXXing Xiang
Xing Xiang
ZZZhenzhen Zhao
Zhenzhen Zhao
JCJiajia Chen
Jiajia Chen
CDCongkun Du
Congkun Du
XJXin Ji
Xin Ji
YZYanhua Zhang
Yanhua Zhang